George Adi Mor
Chief Scientific Officer at Chemomab Therapeutics Ltd. American Depositary Share
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 8 months
- Director since
- 2026
8 months of board service in total across 1 board, counting each seat separately. Longest: Chemomab Therapeutics Ltd. American Depositary Share, 8 months.
Chief executive roles
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 29, 2026 | Chemomab Therapeutics Ltd. American Depositary Share | Open-market purchase | −4,878 | $2.05 | $10,000 |
| May 29, 2026 | Chemomab Therapeutics Ltd. American Depositary Share | Open-market purchase | −4,926 | $2.08 | $10,246 |
| May 29, 2026 | Chemomab Therapeutics Ltd. American Depositary Share | Other | −31,712 | — | — |
| May 29, 2026 | Chemomab Therapeutics Ltd. American Depositary Share | Other | −18,750 | — | — |
| Jan 3, 2023 | Chemomab Therapeutics Ltd. American Depositary Share | Open-market sale | −7,700 | $5.03 | $38,731 |
| Jan 3, 2023 | Chemomab Therapeutics Ltd. American Depositary Share | Open-market sale | −6,100 | $5.03 | $30,683 |
Questions about George Adi Mor
What boards is George Adi Mor on?
George Adi Mor sits on the board of Chemomab Therapeutics Ltd. American Depositary Share.
What company is George Adi Mor the CEO of?
George Adi Mor has been Chief Executive Officer of Chemomab Therapeutics Ltd. American Depositary Share since March 2026.
How long has George Adi Mor served on boards?
Our records show at least 8 months of board service across 1 board, the earliest from 2026.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.